Cardiac Electrophysiology Technologists are specialized healthcare professionals who assist in diagnosing and treating disorders related to the heart’s electrical system. They play a critical role in performing and supporting diagnostic tests such as electrocardiograms (ECGs), Holter monitoring, and invasive electrophysiology studies. These technologists prepare patients, operate sophisticated equipment, and ensure accurate data collection to help physicians pinpoint arrhythmias, conduction abnormalities, and other electrical disturbances. Their technical expertise is vital for guiding therapeutic interventions including catheter ablations and device implantations, which restore normal heart rhythm and improve patient outcomes.
Working closely with electrophysiologists and cardiologists, cardiac electrophysiology technologists also provide patient education and support during complex procedures. They maintain and troubleshoot advanced monitoring systems and contribute to research that advances the understanding of cardiac electrical disorders. Their role requires meticulous attention to detail, strong technical skills, and the ability to respond quickly during emergencies. By combining clinical knowledge with technical proficiency, these specialists enhance the efficiency and safety of electrophysiology labs, ultimately improving care for patients with arrhythmias and other cardiac conduction issues. Their dedication ensures that cutting-edge cardiac therapies are delivered effectively and safely. They are also instrumental in training new technologists, helping to maintain high standards in electrophysiology practice.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India